Shopping Cart
- Remove All
- Your shopping cart is currently empty
BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | 36 € | In Stock | |
10 mg | 56 € | In Stock | |
25 mg | 112 € | In Stock | |
50 mg | 187 € | In Stock | |
100 mg | 283 € | In Stock | |
200 mg | 400 € | In Stock | |
1 mL x 10 mM (in DMSO) | 40 € | In Stock |
Description | BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro. |
In vitro | The inhibition of BTZ-resistant DprE1 followed the trend observed in the MIC measurements, with the C387 g mutant being more resistant to inhibition by PyrBTZ01, PyrBTZ02, and BTZ043 (7- to 9-fold increases in IC50) than the C387S mutant (2.5- to 4-fold increases in IC50). |
In vivo | BTZ-043 was administered at 100 mg/kg (b.i.d., p.o.), and sulfamethoxazole/trimethoprim (SXT), at 100 mg/kg sulfamethoxazole, was used as a positive control. |
Molecular Weight | 431.39 |
Formula | C17H16F3N3O5S |
Cas No. | 1161233-85-7 |
Smiles | C[C@H]1COC2(CCN(CC2)c2nc(=O)c3cc(cc([N+]([O-])=O)c3s2)C(F)(F)F)O1 |
Relative Density. | 1.683 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 15 mg/mL (34.77 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.